Pharmaceutical Executive-12-20-2006

Pharmaceutical Executive

December 20, 2006

Analysts say Times' accusatory articles on Zyprexa are nothing to get excited about.

Pharmaceutical Executive

December 20, 2006

FDA's revisions to guidelines on expanding access to experimental drugs intensify an already murky issue for pharma.

Pharmaceutical Executive

December 20, 2006

At its annual pipeline debut, the company introduced its own CETP-inhibitor--with doubts.